Dow Up 0.11% Nasdaq Up 0.50%

Novavax, Inc. (NVAX)

-NasdaqGS
4.69 Up 0.07(1.52%) Aug 29, 4:00PM EDT
|After Hours : 4.72 Up 0.03 (0.64%) Aug 29, 7:59PM EDT
Prev Close:4.62
Open:4.62
Bid:4.61 x 2000
Ask:4.72 x 1000
1y Target Est:10.40
Beta:1.04
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.56 - 4.71
52wk Range:2.68 - 6.95
Volume:1,463,895
Avg Vol (3m):3,762,700
Market Cap:1.12B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXUp 1.52%1.12B
MRKUp 0.18%173.40B
NVSUp 0.12%217.97B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.28
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback